This analysis synthesizes 5 sources published the week ending Jul 27, 2026. Editorial analysis by the PhysEmp Editorial Team.

Medicare physician payments face a fifth consecutive year of effective cuts just as ambulatory surgery centers confront a $51,000 gap between published CRNA salaries and actual employment costs. This divergence—declining professional fee reimbursement meeting escalating advanced practice provider compensation—is reshaping the economics of Physician Compensation & Demand across outpatient care settings. The result is a structural squeeze that affects not just what physicians earn, but how care delivery models are staffed and financed.

The Reimbursement Ratchet

CMS’s proposed CY 2027 Medicare Physician Fee Schedule sets the conversion factor at $32.8409 for most clinicians—down 1.68% from 2026 rates. The reduction stems largely from the expiration of a one-year 2.5% conversion factor boost Congress included in the Working Families Tax Cut legislation for CY 2026 only. Without new legislation, current law reverts to a reduction relative to 2026 rates.

When adjusted for inflation, Medicare physician payments have declined 33% from 2001 to 2025, according to American Medical Association data. The proposed 2027 rates would extend that erosion into a fifth consecutive cycle of effective pay reductions. Specialty societies including the American College of Surgeons and ASCO are pressing Congress for another patch, but annual last-minute fixes have become the norm instead of the exception.

The problem isn’t the conversion factor by itself. It’s the lack of any mechanism to align physician reimbursement with practice cost inflation. Each patch pushes the mismatch forward and keeps practice leaders guessing.

The companion CY 2027 OPPS/ASC proposed rule moves the other way, increasing facility payment rates by 2.4% with a proposed ASC conversion factor of $57.766 for quality-compliant facilities. Approximately 618 procedures are proposed for addition to the ASC-covered procedures list. That split creates a clear tension: facilities gain room to bring in higher-acuity cases just as the physicians performing those cases face another pay cut.

The Hidden Cost of APP Coverage

While physician professional fees decline, the cost of staffing those same facilities with advanced practice providers is climbing—and the gap between headline salaries and actual employment costs is widening. The average annual CRNA total compensation now stands at $291,396, according to Marit Health’s compilation of peer-reported salaries. But that figure understates the true cost to employers.

Accounting for employer FICA contributions ($22,292), malpractice insurance averaging $5,968 (nearly 50% higher than other non-physician providers), health benefits ($8,500), continuing education and licensing ($3,000), and retirement matching ($11,656) pushes the fully loaded cost to about $342,812—a roughly $51,000 gap over the base salary most administrators budget for. That estimate leaves out paid-time-off backfill and stipend payments, which add more.

The share of ASCs expecting to pay anesthesia stipends jumped from 28% in 2024 to 44% in 2025. For nearly half of centers, the actual cost of CRNA coverage exceeds even the loaded figure above. Meanwhile, average professional anesthesia reimbursement fell 5.5% from 2019 to 2023, and UnitedHealthcare’s 15% CRNA reimbursement cut in select states arrived on top of that decline.

Divergent Strategies Emerge

Faced with this math, ASC leaders are landing in different places. VMG Health data shows 44% planning contractor arrangements with stipends and another 36% using contractors without them, leaving employed and traditional group-coverage models a shrinking minority. Some leaders treat the stipend as a negotiated contract term tied to coverage guarantees and performance metrics. Others are moving toward direct employment, arguing it provides control over staffing and coverage reliability even if it doesn’t lower total cost.

The anesthesia service line can generate facility revenue but increasingly fails to cover its own costs. That shifts the compensation question away from program-level accounting and toward who in the enterprise will subsidize clinical coverage, for how long, and on what terms.

One clinic director described the trade-offs plainly: hire CRNAs and accept a growing subsidy from facility margins, convert more cases to the ASC and hope volume makes up the shortfall, or try to push costs back to payers and hope they agree. None of those options feels stable. Morning huddles now include finance people in the room more often, and those conversations are less about scheduling than about where the next dollar of margin will come from.

Expect more experimentation—stipends tied to minimum coverage windows, hybrid contractor-employed models, and tighter coupling of scheduling to expected payer mix. Expect also more tension when a surgeon wants to move a case to an ASC because the facility can take it, while the professional side sees a shrinking return.

That messy push-and-pull will play out in boardrooms and OR suites, and in worklists and pay stubs. For now, the picture is a series of stopgaps and local fixes rather than a system-level fix. Morning huddles, balance sheets, and the occasional late-night text from an OR director are where the next decisions get made.